Results 111 to 120 of about 4,461,121 (140)

RBM43 promotes glioma aggressiveness and shapes the immune microenvironment through macrophage polarization. [PDF]

Discov Oncol
Tan Z, Wang D, Tang X, He W, Chen Z, Lv Q, Shen X.   +6 more
europepmc   +1 more source

mRNA-based MRI contrast agent for precise diagnosis of glioma and pseudoprogression. [PDF]

Cell Biomater
Li H, Wang L, Zhong Y, Guo K, Xue Y, Wang C, Wang S, Hou X, Chen DS, Liu Z, Cao D, Tian M, Kang DD, Mu X, Deng B, McComb DW, Taouli B, Brown BD, Dong Y.   +18 more
europepmc   +1 more source

Design and Biological Evaluation of ALKBH2 and ALKBH5 Inhibitors as Adjuvants to Temozolomide-Based Glioblastoma Treatment. [PDF]

Biology (Basel)
Rivara M, Malacrida A, Ghizzi M, Bentivegna A, Sica FS, Re F, Motta S, Callea L, Bonati L, Incerti M, Zuliani V, Nicolini G.   +11 more
europepmc   +1 more source

Attract to kill: Exploring the potential of motility trapping as a novel treatment strategy for high-grade gliomas. [PDF]

Neuro Oncol
Bamelis AS, Metselaar DS, Sie M, Lootens T, Willems L, Raedt R, Vandersteene J.   +6 more
europepmc   +1 more source

The role and mechanism of tubulin folding cofactor B in glioblastoma migration. [PDF]

Cell Death Discov
Zhang B, Wang Q, Ouyang C, Yang M, Chen Q, Chen X, Gao F, Liu H.   +7 more
europepmc   +1 more source

Association Between Temozolomide Resistance and Long Non-Coding RNA Expression Profiles in Glioblastoma Cell Lines. [PDF]

Pharmaceuticals (Basel)
Hudáková Z, Hudák Ľ, Hatoková Z, Račay P, Hatok J.   +4 more
europepmc   +1 more source

From bioinformatics to bedside: PPBP drives glioblastoma progression under hypoxia via CXCR2/PI3K/Akt signaling and is targetable by Oenothein B. [PDF]

Cancer Cell Int
Cao X, Fan Y, Wang J, Wang K, Wang X, Cao X, Zong D, Shao J.   +7 more
europepmc   +1 more source

IDH1 Mutant Glioma Favors Group 3 Innate Lymphoid Cells and Is Resistant to Immune Checkpoint Expression. [PDF]

Inflamm Res
Erdem S, Haliloglu Y, Uslu IN, Houran M, Ulutabanca H, Vural A, Erturhan MB, Canatan H, Eken A.   +8 more
europepmc   +1 more source

In vitro evidence that perampanel modulates miR-21-5p and miR-29a-3p associated with anti-glioma effects. [PDF]

Discov Oncol
Donzelli S, Orlandi G, Maschio M, D'Urso A, Rutigliano D, Pellegatta S, Blandino G, Salmaggi A, Ciusani E.   +8 more
europepmc   +1 more source

Novel curcumin derivative DMC-GF suppresses glioblastoma growth by targeting MAPK1 and TRIM21 to modulates STAT3/AKT phosphorylation. [PDF]

Discov Oncol
Xia M, Shi L, Li XT, Huang YL, Wang ZM.
europepmc   +1 more source